Characterization of ST2 transgenic mice with resistance to IL-33

European Journal of Immunology

Volumn 40, Issue 9, 2010, Pages 2632-2642

  Ohto Ozaki, Hiromi ^a   Kuroiwa, Kenji ^a   Mato, Naoko ^a   Matsuyama, Yasushi ^a   Hayakawa, Morisada ^a   Tamemoto, Hiroyuki ^a   Tominaga, Shin Ichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

IL 33; M ; ST2; Transgenic mice

Indexed keywords

IL1RL1 PROTEIN, MOUSE; IL33 PROTEIN, HUMAN; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR;

ANIMAL; BIOSYNTHESIS; BLOOD; C3H MOUSE; CELL MOTION; DOWN REGULATION; DRUG EFFECTS; EOSINOPHIL; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; PERITONEUM MACROPHAGE; SPLENOMEGALY; TH2 CELL; TRANSGENIC MOUSE;

ANIMALS; CELL MOVEMENT; DOWN-REGULATION; EOSINOPHILS; FEMALE; INTERLEUKIN-13; INTERLEUKIN-5; INTERLEUKINS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C3H; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN; SPLENOMEGALY; TH2 CELLS;

EID: 77956467548     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200940291     Document Type: Article

References (46)

1. Tominaga, S., A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett. 1989. 258: 301-304.
2. Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T. and Tominaga, S., Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 1993. 318: 83-87.
3. Bergers, G., Reikerstorfer, A., Braselmann, S., Graninger, P. and Busslinger, M., Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 1994. 13: 1176-1188.
4. Kumar, S., Tzimas, M. N., Griswold, D. E. and Young, P. R., Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem. Biophys. Res. Commun. 1997. 235: 474-478.
5. Saccani, S., Polentarutti, N., Penton-Rol, G., Sims, J. E. and Mantovani, A., Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo. Cytokine 1998. 10: 773-780.
6. Oshikawa, K., Yanagisawa, K., Tominaga, S. and Sugiyama, Y., ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation. Biochem. Biophys. Res. Commun. 2002. 299: 18-24.
7. Weinberg, E. O., Shimpo, M., De Keulenaer, G. W., MacGillivray, C., Tominaga, S., Solomon, S. D., Rouleau, J. L. and Lee, R. T., Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 2002. 106: 2961-2966.
8. Oshikawa, K., Yanagisawa, K., Tominaga, S. and Sugiyama, Y., Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin. Exp. Allergy 2002. 32: 1520-1526.
9. Kuroiwa, K., Arai, T., Okazaki, H., Minota, S. and Tominaga, S., Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem. Biophys. Res. Commun. 2001. 284: 1104-1108.
10. Oshikawa, K., Kuroiwa, K., Tago, K., Iwahana, H., Yanagisawa, K., Ohno, S., Tominaga, S. and Sugiyama, Y., Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am. J. Respir. Crit. Care Med. 2001. 164: 277-281.
11. Tajima, S., Oshikawa, K., Tominaga, S. and Sugiyama, Y., The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 2003. 124: 1206-1214.
12. Weinberg, E. O., Shimpo, M., Hurwitz, S., Tominaga, S., Rouleau, J. L. and Lee, R. T., Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 2003. 107: 721-726.
13. Sweet, M. J., Leung, B. P., Kang, D., Sogaard, M., Schulz, K., Trajkovic, V., Campbell, C. C. et al., A novel pathway regulating lipopolysaccharide- induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol. 2001. 166: 6633-6639.
14. Fagundes, C. T., Amaral, F. A., Souza, A. L., Vieira, A. T., Xu, D., Liew, F. Y., Souza, D. G. and Teixeira, M.M., ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. J. Leukoc. Biol. 2007. 81: 492-499.
15. Leung, B. P., Xu, D., Culshaw, S., McInnes, I. B. and Liew, F. Y., A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J. Immunol. 2004. 173: 145-150.
16. Mato, N., Fujii, M., Hakamata, Y., Kobayashi, E., Sato, A., Hayakawa, M., Ohto-Ozaki, H. et al., Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury. Eur. Respir. J. 2009. 33: 1415-1428.
17. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G. et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005. 23: 479-490.
18. Kondo,Y., Yoshimoto, T.,Yasuda, K., Futatsugi-Yumikura, S.,Morimoto, M., Hayashi, N., Hoshino, T. et al., Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 2008. 20: 791-800.
19. Suzukawa, M., Iikura, M., Koketsu, R., Nagase, H., Tamura, C., Komiya, A., Nakae, S. et al., An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol. 2008. 181: 5981-5989.
20. Cherry,W. B., Yoon, J., Bartemes, K. R., Iijima, K. and Kita, H., A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 2008. 121: 1484-1490.
21. Bourgeois, E., Van, L. P., Samson, M., Diem, S., Barra, A., Roga, S., Gombert, J. M. et al., The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur. J. Immunol. 2009. 39: 1046-1055.
22. Chackerian, A. A., Oldham, E. R., Murphy, E. E., Schmitz, J., Pflanz, S. and Kastelein, R. A., IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 2007. 179: 2551-2555.
23. Li, H.,Willingham, S. B., Ting, J. P.-Y. and Re, F., Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 2008. 181: 17-21.
24. Cayrol, C. and Girard, J. P., The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 2009. 106: 9021-9026.
25. Matsuyama, Y., Okazaki, H., Tamemoto, H., Kimura, H., Kamata, Y., Nagatani, K., Nagashima, T. et al., Increased levels of interleukin-33 in sera and synovial fluids from patients with active rheumatoid arthritis. J. Rheumatol. 2010. 37: 18-25.
26. Hayakawa, M., Hayakawa, H., Matsuyama, Y., Tamemoto, H., Okazaki, H. and Tominaga, S., Mature interleukin-33 is produced by calpain-mediated cleavage in vivo. Biochem. Biophys. Res. Commun. 2009. 387: 218-222.
27. Sakashita,M., Yoshimoto, T., Hirota, T., Harada, M., Okubo, K., Osawa, Y., Fujieda, S. et al., Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis. Clin. Exp. Allergy 2008. 38: 1875-1881.
28. Lingel, A.,Weiss, T. M., Niebuhr,M., Pan, B., Appleton, B. A.,Wiesmann, C., Bazan, J. F. and Fairbrother,W. J., Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure 2009. 17: 1398-1410.
29. Funakoshi-Tago, M., Tago, K., Hayakawa, M., Tominaga, S., Ohshio, T., Sonoda, Y. and Kasahara, T., TRAF6 is a critical signal transducer in IL-33 signaling pathway. Cell Signal. 2008. 20: 1679-1686.
30. Kurowska-Stolarska, M., Kewin, P., Murphy, G., Russo, R. C., Stolarski, B., Garcia, C. C., Komai-Koma, M. et al., IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 2008. 181: 4780-4790.
31. Jones, L. A., Roberts, F., Nickdel, M. B., Brombacher, F., McKenzie, A. N., Henriquez, F. L., Alexander, J. and Roberts, C. W., IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur. J. Immunol. 2010. 40: 426-436.
32. Mayuzumi, N., Matsushima, H. and Takashima, A., IL-33 promotes DC development in BM culture by triggering GM-CSF production. Eur. J. Immunol. 2009. 39: 3331-3342.
33. Hayakawa, H., Hayakawa, M., Kume, A. and Tominaga, S., Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J. Biol. Chem. 2007. 282: 26369-26380.
34. Niwa, H., Yamamura, K. and Miyazaki, J., Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991. 108: 193-199.
35. Espinassous, Q., Garcia-de-Paco, E., Garcia-Verdugo, I., Synguelakis, M., von Aulock, S., Sallenave, J. M., McKenzie, A. N. J. and Kanellopoulos, J., IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J. Immunol. 2009. 183: 1446-1455.
36. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A. and Locati, M., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004. 25: 677-686.
37. Kurowska-Stolarska, M., Stolarski, B., Kewin, P., Murphy, G., Corrigan, C. J., Ying, S., Pitman, N. et al., IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 2009. 183: 6469-6477.
38. Hazlett, L. D., McClellan, S. A., Barrett, R. P., Huang, X., Zhang, Y.,Wu, M., van Rooijen, N. and Szliter, E., IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 2010. 51: 1524-1532.
39. Anderson, C. F., and Mosser, D. M., A novel phenotype for an activated macrophage: the type 2 activated macrophage. J. Leukoc. Biol. 2002. 72: 101-106.
40. Gerber, J. S. and Mosser, D. M., Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. J. Immunol. 2001. 166: 6861-6868.
41. Pushparaj, P. N., Tay, H. K., H'ng, S. C., Pitman, N., Xu, D., McKenzie, A., Liew, F. Y. and Melendez, A. J., The cytokine interleukin-33 mediates anaphylactic shock. Proc. Natl. Acad. Sci. USA 2009. 106: 9773-9778.
42. Verri,W. A., Jr., Guerrero, A. T., Fukada, S. Y., Valerio, D. A., Cunha, T. M., Xu, D., Ferreira, S. H. et al., IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc. Natl. Acad. Sci. USA 2008. 105: 2723-2728.
43. Smithgall, M. D., Comeau, M. R., Yoon, B. R., Kaufman, D., Armitage, R. and Smith, D. E., IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 2008. 20: 1019-1030.
44. Brinster, R. L., Chen, H. Y., Trumbauer, M. E., Yagle, M. K. and Palmiter, R. D., Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc. Natl. Acad. Sci. USA 1985. 82: 4438-4442.
45. Takagi, T., Yanagisawa, K., Tsukamoto, T., Tetsuka, T., Nagata, S. and Tominaga, S., Identification of the product of the murine ST2 gene. Biochim. Biophys. Acta 1993. 1178: 194-200.
46. Kimata, Y., Iwaki, M., Lim, C. R. and Kohno, K., A novel mutation which enhances the fluorescence of green fluorescent protein at high temperatures. Biochem. Biophys. Res. Commun. 1997. 232: 69-73.